|
Re: Presentation
|
2
|
Resverlogix Corp.
|
May 13, 2021 05:19PM
|
|
Presentation
|
4
|
Resverlogix Corp.
|
May 13, 2021 02:53PM
|
|
Re: RESVERLOGIX CORP WTS 2021
|
1
|
Resverlogix Corp.
|
May 11, 2021 03:10PM
|
|
Re: RESVERLOGIX CORP WTS 2021
|
2
|
Resverlogix Corp.
|
May 11, 2021 10:55AM
|
|
Re: Covid Therapeutics Tracker
|
2
|
Resverlogix Corp.
|
May 08, 2021 10:53AM
|
|
Re: Covid Therapeutics Tracker
|
1
|
Resverlogix Corp.
|
May 08, 2021 10:20AM
|
|
Re: Covid Therapeutics Tracker
|
1
|
Resverlogix Corp.
|
May 08, 2021 10:19AM
|
|
Covid Therapeutics Tracker
|
3
|
Resverlogix Corp.
|
May 08, 2021 09:58AM
|
|
Re: As we appear to have a flat tire down at the registry...you then read this from Fauci!
|
7
|
Resverlogix Corp.
|
May 07, 2021 10:08AM
|
|
Re: Deloitte
|
1
|
Resverlogix Corp.
|
May 06, 2021 01:38PM
|
|
Re: Deloitte
|
6
|
Resverlogix Corp.
|
May 06, 2021 01:34PM
|
|
Re: New exempt distribution
|
6
|
Resverlogix Corp.
|
May 06, 2021 11:25AM
|
|
Re: Presentation May 12th
|
1
|
Resverlogix Corp.
|
May 06, 2021 09:52AM
|
|
Re: Financing-Move On
|
5
|
Resverlogix Corp.
|
May 05, 2021 04:31PM
|
|
Re: Financing-Move On
|
9
|
Resverlogix Corp.
|
May 05, 2021 01:17PM
|
|
Financing-Move On
|
2
|
Resverlogix Corp.
|
May 05, 2021 11:13AM
|
|
Re: Farxiga (SGLT2i) approved for CKD patients with AND without T2D
|
|
Resverlogix Corp.
|
May 03, 2021 02:19PM
|
|
Re: Farxiga (SGLT2i) approved for CKD patients with AND without T2D
|
2
|
Resverlogix Corp.
|
May 02, 2021 03:20PM
|
|
Re: Still no trial.....wow (people are still dying)
|
3
|
Resverlogix Corp.
|
Apr 30, 2021 03:35PM
|
|
Re: One more Exempt Distribution - 2021-04-26
|
3
|
Resverlogix Corp.
|
Apr 28, 2021 10:44AM
|
